Term Acronym Related terms Definition A form containing details of a patient and their medical condition for which a prescriber wishes to prescribe Authorisation request immunoglobulin treatment, used to obtain initial access to the supply of government-funded immunoglobulin product. A person or responsible for overseeing authorisation requests Authoriser for immunoglobulin products and delegating the approval or rejection of an authorisation request. A web-based system that allows staff in health providers (hospitals) across BloodNet Australia to order and receipt blood and blood products. A web-based system that facilitates authorisation for access and management BloodSTAR of immunoglobulin products for the treatment of medical conditions identified in the Criteria. Clinical conditions are categorised according to the quality of the available Condition Diagnosis evidence and whether immunoglobulin treatment is considered beneficial. A situation where therapy should not be Contraindicated used because it may be harmful to the patient. The CHC is responsible for overseeing and managing the blood sector. It sets Council of Australian CHC the governance, policy and financial Governments Health Council frameworks under which the NBA operates. Identifies the indications for which IVIg is funded under national blood arrangements by all Australian Criteria for the clinical governments; the book is not a medical use of intravenous or clinical guideline on treatment of the Criteria immunoglobulin in Australia, indications listed. Regular review of the Second Edition 2012. Criteria is needed to align funded access to IVIg with the latest evidence, or in the case of limited evidence, a consensus of expert opinion. Condition determined from medical Diagnostic conditions examination of signs and symptoms and other investigations.
Term Acronym Related terms Definition Authorisation request A form containing details of a patient and their medical condition for which a prescriber wishes to prescribe immunoglobulin treatment, used to obtain initial access to the supply of government-funded immunoglobulin product. Authoriser A person or responsible for overseeing authorisation requests for immunoglobulin products and delegating the approval or rejection of an authorisation request. BloodNet A web-based system that allows staff in health providers (hospitals) across Australia to order and receipt blood and blood products. BloodSTAR A web-based system that facilitates authorisation for access and management of immunoglobulin products for the treatment of medical conditions identified in the Criteria. Condition Diagnosis Clinical conditions are categorised according to the quality of the available evidence and whether immunoglobulin treatment is considered beneficial. Contraindicated A situation where therapy should not be used because it may be harmful to the patient. Council of Australian Governments Health Council CHC The CHC is responsible for overseeing and managing the blood sector. It sets the governance, policy and financial frameworks under which the NBA operates. Criteria for the clinical use of intravenous immunoglobulin in Australia, Second Edition 2012. Criteria Identifies the indications for which IVIg is funded under national blood arrangements by all Australian governments; the book is not a medical or clinical guideline on treatment of the indications listed. Regular review of the Criteria is needed to align funded access to IVIg with the latest evidence, or in the case of limited evidence, a consensus of expert opinion. Diagnostic conditions Condition determined from medical examination of signs and symptoms and other investigations.
2016-immunoglobulin-governance-national-policy-updatev4.docx